homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

September 14, 2004

ZymoGenetics

Seattle-based ZymoGenetics named Douglas E. Williams chief scientific officer and executive vice president to work on research and development. Williams was chief technical officer of Immunex Corp., and most recently chief scientific officer of research and development at Bothell-based Seattle Genetics. Frank Collins is retiring as chief scientific officer. ZymoGenetics is a biopharmaceutical company that works on therapeutic proteins for prevention or treatment of human diseases.




Email or user name:
Password:
 
Forgot password? Click here.